A recent report from the Centers for Disease Control (CDC) indicates that at least 52 Utahns from October 2017 through January 2018 experienced severe sickness as a result of ingesting a product claiming to contain cannabidiol (CBD), a nonpsychoactive compound produced by the cannabis plant.
Tests revealed that the poisonous substance, often marketed as “Yolo CBD oil” in various shops around Utah, did not have any CBD. Instead the product contained a synthetic chemical known as 4-CCB, which caused 31 Utahns to end up in the emergency room with symptoms ranging from seizures to hallucinations.
As information about its therapeutic effects has spread, CBD has received a great deal of attention in recent years. Consumers who purchased “Yolo CBD oil” believed they were buying something with no psychoactive effects, and many of them intended to use it for health-related reasons.
These kinds of dangerous situations could be avoided with a well-regulated medical cannabis program in Utah. The Utah Medical Cannabis Act requires cannabis products to be tested and labeled accurately, so patients know what they are consuming.